Cart
sales@molnova.com
Stearyldiethanolamine
CAS No. 10213-78-2
Stearyldiethanolamine( 2,2'-(Octadecylazanediyl)diethanol | PEG-2 Stearamine | 2,2'-(Octadecylimino)diethanol )
Catalog No. M26466 CAS No. 10213-78-2
Stearyldiethanolamine can be used in studies about antibacterial nonwoven fabric and antibacterial freshness-keeping film.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | 29 | In Stock |
|
| 500MG | 45 | In Stock |
|
| 1G | 68 | In Stock |
|
Biological Information
-
Product NameStearyldiethanolamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionStearyldiethanolamine can be used in studies about antibacterial nonwoven fabric and antibacterial freshness-keeping film.
-
DescriptionStearyldiethanolamine can be used in studies about antibacterial nonwoven fabric and antibacterial freshness-keeping film.
-
In Vitro——
-
In Vivo——
-
Synonyms2,2'-(Octadecylazanediyl)diethanol | PEG-2 Stearamine | 2,2'-(Octadecylimino)diethanol
-
PathwayOthers
-
TargetOther Targets
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number10213-78-2
-
Formula Weight357.623
-
Molecular FormulaC22H47NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 100 mg/mL (279.63 m)
-
SMILESCCCCCCCCCCCCCCCCCCN(CCO)CCO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Szymańska B, D?ugosz A. The role of the BLCA-4 nuclear matrix protein in bladder cancer. Postepy Hig Med Dosw (Online). 2017 Aug 13;71(1):681-689. Review.
molnova catalog
related products
-
SU 4313
SU 4313 is a bioactive chemical.
-
16,17-Didehydroganod...
3,11,15,23-Tetraoxo-27ξ-lanosta-8,16-dien-26-oic acid, a lanostane-type triterpenoid, is isolated from Antrodia camphorate.
-
Compound K
HIV-IN-11 is part of the hydroxylaminoglutaramide (HAPA) transition state isomeric series of HIV protease inhibitors and is a potent and selective inhibitor of HIV-1 protease. HIV-IN-11 competitively inhibits HIV-1 PR (Ki: 0.049 nM) and potently inhibits replication of HIV(IIIb)-infected MT4 lymphocytes at concentrations of 25.0-50.0 nM. HIV-IN-11 displays a longer half-life than indinavir sulfate in animal models and serves as a promising second-generation HIV protease inhibitor.
